Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,765,000 | 14,598,000 | 8,277,000 | 5,063,000 | 1,803,000 |
| Depreciation Amortization | 1,774,000 | 7,655,000 | 5,548,000 | 3,892,000 | 2,221,000 |
| Income taxes - deferred | 927,000 | 2,198,000 | 120,000 | -106,000 | -404,000 |
| Accounts receivable | N/A | 367,000 | N/A | N/A | N/A |
| Other Working Capital | -3,327,000 | -2,367,000 | -3,342,000 | -2,925,000 | -1,533,000 |
| Other Operating Activity | 164,000 | -5,705,000 | 1,195,000 | 871,000 | 687,000 |
| Operating Cash Flow | $2,303,000 | $16,746,000 | $11,798,000 | $6,795,000 | $2,774,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,952,000 | 2,743,000 | 6,273,000 | 2,963,000 | 2,398,000 |
| PPE Investments | -202,000 | -1,327,000 | -833,000 | -548,000 | -254,000 |
| Net Acquisitions | N/A | 10,800,000 | -782,000 | -782,000 | -782,000 |
| Purchase Of Investment | -2,246,000 | -11,145,000 | -8,694,000 | -2,317,000 | -1,184,000 |
| Sale Of Investment | 1,444,000 | 4,990,000 | 3,357,000 | 304,000 | 302,000 |
| Purchase Sale Intangibles | -126,000 | -92,000 | N/A | N/A | N/A |
| Other Investing Activity | 30,000 | 93,000 | -4,000 | -56,000 | -29,000 |
| Investing Cash Flow | $-10,926,000 | $6,154,000 | $-683,000 | $-436,000 | $451,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,516,000 | 7,965,000 | 5,524,000 | 3,415,000 | -230,000 |
| Debt Issued | 2,624,000 | N/A | 0 | N/A | N/A |
| Debt Repayment | -2,000 | -1,513,000 | -14,000 | -7,000 | -3,000 |
| Common Stock Issued | 642,000 | 568,000 | 355,000 | 198,000 | 35,000 |
| Common Stock Repurchased | -4,626,000 | -8,228,000 | -4,834,000 | -2,999,000 | -1,659,000 |
| Dividend Paid | -1,735,000 | -6,534,000 | -4,915,000 | -3,283,000 | -1,650,000 |
| Other Financing Activity | -985,000 | -8,257,000 | -5,882,000 | -3,799,000 | 0 |
| Financing Cash Flow | $434,000 | $-15,999,000 | $-9,766,000 | $-6,475,000 | $-3,507,000 |
| Exchange Rate Effect | N/A | -2,000 | -25,000 | -35,000 | 34,000 |
| Beginning Cash Position | 10,081,000 | 3,182,000 | 3,182,000 | 3,182,000 | 3,182,000 |
| End Cash Position | 1,892,000 | 10,081,000 | 4,506,000 | 3,031,000 | 2,934,000 |
| Net Cash Flow | $-8,189,000 | $6,899,000 | $1,324,000 | $-151,000 | $-248,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,303,000 | 16,746,000 | 11,798,000 | 6,795,000 | 2,774,000 |
| Capital Expenditure | -202,000 | -1,327,000 | -833,000 | -548,000 | -254,000 |
| Free Cash Flow | 2,101,000 | 15,419,000 | 10,965,000 | 6,247,000 | 2,520,000 |